References
- Baldacchino, A., & Corkery, J. (2006). Comorbidity research in Europe in perspectives across Europe. In A. Baldacchino & J. Corkery (Eds.), European collaborating centres in addiction studies (ECCAS) (pp. 307–330). London: St Georges Hospital Medical School.
- Bucci S, Baker A, Halpin SA, Hides L, Lewin TJ, Carr VJ, Startup M. Intervention for cannabis use in young people at ultra high risk for psychosis and in early psychosis. Mental Health and Substance Use: Dual Diagnosis 2010; 3: 66–73
- Chen S, Barnett PG, Sempel JM, Timko C. Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients’ symptom severity. Journal of Substance Abuse Treatment 2006; 31: 95–105
- Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bod GR. Review of integrated mental health and substance abuse treatment for patients with dual diagnosis. Schizophrenia Bulletin 1998; 24: 589–608
- EMCDDA (2004). Annual report: Selected issue 3: Co-morbidity: The state of the drugs problem in the European Union and Norway (pp. 94–102). Luxembourg: European Monitoring Centre for Drugs and Drug Addiction, European Communities. Retrieved from http://annualreport.emcdda.eu.int
- EMCDDA (2005). Co-morbidity: Drug use and mental disorders. Drugs in focus issue 14. Lisbon: European Monitoring Centre for Drugs and Drug Addiction, European Commission. Retrieved from http://www.emcdda.eu.int.
- Flynn PT, Brown BS. Co-occurring disorders in substance abuse treatment: Issues and prospects. Journal of Substance Abuse Treatment 2008; 34: 36–47
- Greacen, T., Baldacchino, A., Charzynska, K., Sorsa, M., Groussard-Escaffre, N., Clancy, C., … , Baeck-Moller, K. (2010). Pathways through care for people with dual diagnosis in Europe: Results from the treatment options for dual diagnosis (TODD) user Zoom instrument. Mental Health and Substance Use: Dual Diagnosis (in press).
- Hodges CL, Patterson S, Taikato M, McGarrol S, Crome I, Baldacchino A. Co-morbid mental health and substance misuse in Scotland. Scottish Executive Substance Misuse Research, Edinburgh 2006
- Lowe AL, Abou-Saleh MT. The British experience of dual diagnosis in the National Health Service. Acta Neuropsychiatrica 2004; 16: 41–46
- McGovern MP, Matzkin AL, Giard J. Assessing the dual diagnosis capability of addiction treatment services: The dual diagnosis capability in addiction treatment DDCAT Index. Journal of Dual Diagnosis 2007; 3: 111–124
- Minkoff K. Program components of a comprehensive integrated care system for serious mentally ill patients with substance disorders. Dual diagnosis of major mental illness and substance disorders: New directions for mental health services, K Minkoff, RE Drake. Jossey-Bass, San Francisco 1991; 13–27
- Mueser KT, Noordsy DL, Drake RE, Fox L. Integrated treatment for dual diagnosis: A guide to effective practice. Guilford Press, New York 2003
- Öjehagen A, Schaar I. Mentally ill substance abusers in Sweden: A 5-year follow-up of a multisite study of co-operation between psychiatric services and social authorities. Dual diagnosis: Filling the gap, G Carrà, M Clerici. John Libbey, Eurotext, Paris 2003; 49–54
- Sacks S, McKendrick K, Sacks JY, Banks S, Harle M. Enhanced outpatient treatment for co-occurring disorders. Journal of Substance Abuse Treatment 2008; 34: 48–60
- Scottish Executive (2003). Mind the gaps: Meeting the needs of people with co-occurring substance misuse and mental health problems. Report of the Joint Working Group: Scottish Advisory Committee on Drug Misuse & Scottish Advisory Committee on Alcohol Misuse. Edinburgh: Scottish Executive.
- Staiger PK, Long C, Baker A. Health service systems and comorbidity: Stepping up to the mark. Mental Health and Substance Use: Dual Diagnosis 2010; 3: 148–161
- Weaver T, Renton A, Stimson G. Severe mental illness and substance misuse. British Medical Journal 1999; 319: 137–138